NICE/PHE pneumonia: antimicrobial prescribing guideline
This summary covers an antimicrobial prescribing strategy for patients with community-acquired pneumonia.
Community-acquired pneumonia is a lower respiratory tract infection that is most commonly caused by bacterial infection. The main bacterial pathogen is Streptococcus pneumoniae, however Mycoplasma pneumoniae occurs in outbreaks approximately every 4 years in the UK.
Using antibiotics when they are not needed means they may not work as well in the future. This is a serious health risk so NICE has written advice about when to offer antibiotics for some common conditions.
This guideline sets out an antimicrobial prescribing strategy for adults, young people, children and babies aged 72 hours and over with a confirmed diagnosis of community-acquired pneumonia. It aims to optimise antibiotic use and reduce antibiotic resistance.
This Guidelines summary covers:
- Managing community-acquired pneumonia
- Treatment for adults, young people and children
- Referral and seeking specialist advice
- Choice of antibiotic for:
- adults aged 18 years and over
- children and young people under 18 years